[go: up one dir, main page]

DK3139940T3 - Sammensætning omfattende l. reuteri ler03 og l. salivarius ls06 til anvendelse til behandling af tumorer, aids og leukæmi - Google Patents

Sammensætning omfattende l. reuteri ler03 og l. salivarius ls06 til anvendelse til behandling af tumorer, aids og leukæmi Download PDF

Info

Publication number
DK3139940T3
DK3139940T3 DK15736584.2T DK15736584T DK3139940T3 DK 3139940 T3 DK3139940 T3 DK 3139940T3 DK 15736584 T DK15736584 T DK 15736584T DK 3139940 T3 DK3139940 T3 DK 3139940T3
Authority
DK
Denmark
Prior art keywords
leuchemism
ler03
salivarius
reuteri
tumors
Prior art date
Application number
DK15736584.2T
Other languages
English (en)
Inventor
Giovanni Mogna
Original Assignee
Probiotical Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotical Spa filed Critical Probiotical Spa
Application granted granted Critical
Publication of DK3139940T3 publication Critical patent/DK3139940T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK15736584.2T 2014-05-05 2015-04-30 Sammensætning omfattende l. reuteri ler03 og l. salivarius ls06 til anvendelse til behandling af tumorer, aids og leukæmi DK3139940T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI20140816 2014-05-05
PCT/IB2015/000602 WO2015170158A1 (en) 2014-05-05 2015-04-30 Therapy for use in the treatment of tumors, acquired immunodeficiency syndrome and leukemias by dual immune biostimulation

Publications (1)

Publication Number Publication Date
DK3139940T3 true DK3139940T3 (da) 2021-05-17

Family

ID=51136602

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15736584.2T DK3139940T3 (da) 2014-05-05 2015-04-30 Sammensætning omfattende l. reuteri ler03 og l. salivarius ls06 til anvendelse til behandling af tumorer, aids og leukæmi

Country Status (9)

Country Link
US (2) US10413576B2 (da)
EP (1) EP3139940B1 (da)
JP (1) JP6804984B2 (da)
KR (1) KR20160148651A (da)
CN (1) CN107106629B (da)
CA (1) CA2946463A1 (da)
DK (1) DK3139940T3 (da)
RU (1) RU2721565C2 (da)
WO (1) WO2015170158A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112016024860A2 (pt) 2014-05-05 2017-10-17 Mogna Giovanni composição para uso no tratamento ou prevenção de infecções virais ou bacterianas em um sujeito que passa por quimioterapia antitumor, tratamento de leucemia ou terapia contra aids compreendendo l. reuteri ler03 e/ou l. salivarius l206
EP3139940B1 (en) 2014-05-05 2021-02-17 Probiotical S.p.A. Composition comprising l. reuteri ler03 and l. salivarius ls06 for use in the treatment of tumors, aids and leukemias
AR112328A1 (es) * 2017-07-05 2019-10-16 Evelo Biosciences Inc Composiciones y métodos para tratamiento de cáncer usando bifidobacterium animalis ssp. lactis
WO2019075452A1 (en) * 2017-10-13 2019-04-18 Evelo Biosciences, Inc. IDENTIFICATION OF BACTERIA FOR CANCER THERAPY
AU2021404073A1 (en) * 2020-12-17 2023-07-20 Synbalance Srl Probiotic compositions and their use in the prevention and/or treatment of stress-related conditions
CN113215063B (zh) * 2021-06-16 2023-02-21 中国药科大学 一种唾液乳杆菌及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0814822B1 (en) * 1995-12-21 2003-05-07 BioGaia AB Use of lactobacillus reuteri to inhibit cryptosporidiosis in mammals
CN1370587A (zh) * 2002-03-05 2002-09-25 王舒妍 芦荟凝胶的制备方法
MXPA05003743A (es) * 2002-10-18 2005-06-17 Biogaia Ab Metodo para mejorar la funcion inmunologica en mamiferos utilizando cepas de lactobacillus reuteri.
ITMI20051510A1 (it) * 2005-08-02 2007-02-03 Proge Farm Srl Uso di specifici batteri lattici per la preparazione di composizioni iunomodulanti
JP2007084533A (ja) * 2005-08-24 2007-04-05 Prima Meat Packers Ltd 免疫応答調節組成物及び該組成物を有効成分とする食品
ITTO20070555A1 (it) 2007-07-26 2009-01-27 Bioman S R L Biomassa arricchita in zinco, procedimento per la sua preparazione e prodotti probiotici, cosmetici, dietetici e nutraceutici comprendenti tale biomassa
TWI346554B (en) 2008-04-30 2011-08-11 Genmont Biotech Inc Lactobacillus isolates having anti-inflammatory activities and uses of the same
KR101001767B1 (ko) * 2008-11-04 2010-12-15 주식회사한국야쿠르트 항 인플루엔자 바이러스 효능을 갖는 락토바실러스 루테리 에이취와이7501 및 이를 유효성분으로 함유하는 제품
WO2010077682A2 (en) * 2008-12-08 2010-07-08 James Allen Lemke Treatment of hiv and aids using probiotic lactobacillus reuteri
US20110117210A1 (en) * 2009-11-17 2011-05-19 Andrey Ugolkov Therapeutic treatment of human cancers using simple salts of zinc
US20120107395A1 (en) * 2010-11-01 2012-05-03 Viva Pharmaceutical Inc. Probiotic Soft Gel Compositions
CN102618452B (zh) * 2011-02-01 2014-06-25 任发政 唾液乳杆菌及其代谢物的制备方法和组合物以及应用
ITMI20110679A1 (it) * 2011-04-20 2012-10-21 Giovanni Mogna Composizione comprendente batteri probiotici in grado di ripristinare l effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell iperacidita gastrica.
ITRM20110477A1 (it) * 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
KR20130048946A (ko) * 2011-11-03 2013-05-13 가톨릭대학교 산학협력단 락토바실러스 루테리 ｃｓ132 또는 이의 배양물을 포함하는 항암용 조성물
ITMI20120131A1 (it) 2012-02-01 2013-08-02 Probiotical Spa Batteri probiotici microincapsulati multistrato, loro produzione ed uso
BR112016024860A2 (pt) 2014-05-05 2017-10-17 Mogna Giovanni composição para uso no tratamento ou prevenção de infecções virais ou bacterianas em um sujeito que passa por quimioterapia antitumor, tratamento de leucemia ou terapia contra aids compreendendo l. reuteri ler03 e/ou l. salivarius l206
EP3139940B1 (en) 2014-05-05 2021-02-17 Probiotical S.p.A. Composition comprising l. reuteri ler03 and l. salivarius ls06 for use in the treatment of tumors, aids and leukemias

Also Published As

Publication number Publication date
RU2721565C2 (ru) 2020-05-20
RU2016143922A3 (da) 2018-10-23
EP3139940B1 (en) 2021-02-17
EP3139940A1 (en) 2017-03-15
CN107106629B (zh) 2021-01-12
CA2946463A1 (en) 2015-11-12
RU2016143922A (ru) 2018-06-05
WO2015170158A1 (en) 2015-11-12
US20190350989A1 (en) 2019-11-21
JP6804984B2 (ja) 2020-12-23
JP2017514857A (ja) 2017-06-08
US20170042951A1 (en) 2017-02-16
US10413576B2 (en) 2019-09-17
WO2015170158A8 (en) 2016-12-01
KR20160148651A (ko) 2016-12-26
CN107106629A (zh) 2017-08-29

Similar Documents

Publication Publication Date Title
IL266560A (en) Endophytes, related preparations and methods of using them
DK3212208T3 (da) Anvendelse af l. reuteri til forebyggelse eller behandling af mikrobiotadysbiose tidligt i livet
DK3728121T3 (da) Lanthaniddoterede, lagdelte dobbelthydroxider og fremgangsmåde til fremstilling af samme
DK3154594T3 (da) Fap-aktiverede, terapeutiske midler og anvendelser i forbindelser dermed
BR112016018521A2 (pt) composição, e, kit.
EP3161124A4 (en) Endophytes, associated compositions, and methods of use thereof
LT3102609T (lt) Gamybos būdas autologinių t ląstelių, naudotinų b ląstelių piktybinių navikų ir kitų vėžio rūšių gydymui, bei jų kompozicijos
SG11201702795QA (en) Engineered renal tissues, arrays thereof, and methods of making the same
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK3143134T3 (da) Modificerede, naturlige dræberceller og anvendelser deraf
SG11201607448PA (en) Determining cancer agressiveness, prognosis and responsiveness to treatment
EP3217925A4 (en) Bone graft materials, devices and methods of use
PT3116911T (pt) Anticorpos anti-mcam e métodos de utilização associados
DK2986304T3 (da) Farmaceutisk sammensætning, fremgangsmåder til behandling og anvendelser deraf.
DK3113797T3 (da) Antistoffer, anvendelser og fremgangsmåder
DK3018183T3 (da) Halogenolefinbaseret sammensætning og anvendelse deraf
DK3137168T3 (da) Substituerede 4-phenylpiperidiner, deres fremstilling og anvendelse
HRP20181105T1 (hr) Novi pripravci, upotreba i postupci za njihovo dobivanje
DK3204386T3 (da) Substituerede aminopurinforbindelser, sammensætninger deraf og fremgangsmåder til behandling dermed
IL251028A0 (en) 17a,21-diesters of cortexolone for use in the treatment of tumors
LT3200815T (lt) Būdai ir kompozicijos, skirti vėžio gydymui
DK3242957T3 (da) Bakterieholdige sammensætninger og fremgangsmåder til anvendelse af samme til behandling og/eller forebyggelse af gastrointestinale, metaboliske og/eller andre sygdomme
ZA201903967B (en) Adam9-binding molecules, and methods of use thereof
DK3139940T3 (da) Sammensætning omfattende l. reuteri ler03 og l. salivarius ls06 til anvendelse til behandling af tumorer, aids og leukæmi
DK3236934T3 (da) Farmaceutisk sammensætning, fremstilling og anvendelser deraf